Screener
Abbott ABT Nutritional Products — Operating Earnings
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Abbott in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The source filing: Abbott’s 10-Q, filed July 28, 2026.
- Filed
- Jul 28, 2026, 4:02 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-050134
| (in millions) | Net Sales to External Customers / Three Months Ended June 30, 2026 | Net Sales to External Customers / Three Months Ended June 30, 2025 | Cost of Products Sold / Three Months Ended June 30, 2026 | Cost of Products Sold / Three Months Ended June 30, 2025 | Research and Development / Three Months Ended June 30, 2026 | Research and Development / Three Months Ended June 30, 2025 | Selling, General, and Administrative / Three Months Ended June 30, 2026 | Selling, General, and Administrative / Three Months Ended June 30, 2025 | Operating Earnings / Three Months Ended June 30, 2026 | Operating Earnings / Three Months Ended June 30, 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Established Pharmaceuticals | $1,499 | $1,383 | $(650) | $(631) | $(48) | $(43) | $(419) | $(363) | $382 | $346 |
| Nutritional Products | 2,144 | 2,212 | (1,148) | (1,155) | (54) | (54) | (574) | (585) | 368 | 418 |
| Diagnostic Products | 3,092 | 2,173 | (1,532) | (1,224) | (268) | (154) | (793) | (423) | 499 | 372 |
| Medical Devices | 5,853 | 5,369 | (1,925) | (1,758) | (470) | (430) | (1,489) | (1,385) | 1,969 | 1,796 |
| Total | $12,588 | $11,137 | $(5,255) | $(4,768) | $(840) | $(681) | $(3,275) | $(2,756) | $3,218 | $2,932 |
| Other | 5 | 5 | ||||||||
| Net sales | $12,593 | $11,142 | ||||||||
| Corporate functions and plan benefit costs | (45) | (65) |
Item 1. Financial Statements and Supplementary Data
FAQ
- What is Abbott's nutritional products — operating earnings?
- Abbott (ABT) reported nutritional products — operating earnings of $368M in Q2 2026.
- How has Abbott's nutritional products — operating earnings changed year-over-year?
- Abbott's nutritional products — operating earnings decreased by 12.0% year-over-year, from $418M to $368M.
- What is the long-term trend for Abbott's nutritional products — operating earnings?
- Over 4 years (2021 to 2025), Abbott's nutritional products — operating earnings has grown at a -3.0% compound annual growth rate (CAGR), from $1.76B to $1.56B.
- What does nutritional products — operating earnings mean?
- The profit generated by the nutritional products segment after deducting cost of goods sold and operating expenses, but before interest and taxes. It serves as the primary indicator of the segment's core operational profitability and efficiency.
Ask your AI about Abbott's nutritional products — operating earnings.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude